Decoy Therapeutics is trading at $3.69, up +19.03%, after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses. - The program is pursuing the FDA’s Animal Rule pathway, with government grants and public-health partnerships being pursued to fund development. - A separate warrant-inducement transaction could provide approximately $3.85 million in gross proceeds.